Sodium-coupled monocarboxylate transporter 2

Last updated

Sodium-coupled monocarboxylate transporter 2 (i.e., SMCT2, also termed SLC5A12) is a plasma membrane transport protein in the solute carrier family. It transports sodium cations (i.e., Na+) in association with the anionic forms (see conjugated base) of certain short-chain fatty acids (i.e., SC-FAs) and other agents through the plasma membrane from the outside to the inside of cells. [1] The only other member of the sodium-coupled monocarboxylate transporter group (sometimes referred to as the SLC5A family [2] ), SMCT1, similarly co-transports SC-FAs and other agents into cells. Monocarboxylate transporters (MCTs) are also transport proteins in the solute carrier family. They co-transport the anionic forms of various compounds into cells in association with hydrogen cations (i.e. H+). [3] Four of the 14 MCTs, i.e. SLC16A1 (i.e., MCT1), SLC16A7 (i.e., MCT22), SLC16A8 (i.e., MCT3), and SLC16A3 (i.e., MCT4), transport some of the same SC-FAs anions that the two SMCTs transport into cells. [2] [4] SC-FAs do diffuse into cells independently of transport proteins but at the levels normally occurring in tissues greater amounts of the SC-FAs are brought into cells that express a SC-FA transporter. [1] [3]

Contents

The human gene responsible for producing SMCT2 protein, i.e., the SLC5A12 gene, is located at position 14.2 on the "p" (i.e., short) arm of chromosome 11 (position notated as chromosome 11p14.2). [5] The full length SMCT2 protein product of this gene consist of 618 amino acids [6] and has a 57% identity with the SMCT1 protein at the amino acid level. [7] The gene for SMCT2 in mice and rats is termed the Slc5a12 gene.

Studies indicate that the SMCT2 on intestinal epithelial cells promotes their uptake of intra-intestinal SC-FAs and subsequent diffusion of the SC-FAs into the systemic circulation. These SC-FAs serve as energy sources for [8] and activators of diverse responses in [9] [10] [11] a wide range of cell types in the intestinal wall and throughout the entire body. Studies also suggest that: 1) SMCT2 in the kidney tubule cells contributes to the reabsorption of urinary SC-FAs that would otherwise be wasted in the urine; 2) the SMCT2 on the Müller cells in the eye promotes their uptake SC-FAs which they pass on to retinal neurons that use them as energy sources; [12] and 3) the SCMT2 on skeletal muscle cells may contribute to regulating their lactic acid levels. [13]

Tissues and cells expressing SMCT2

The SMCT2 protein and/or its messenger RNA is expressed by the human and/or murine: epithelial cells in the proximal (i.e., initial and middle portions) of the small intestine; epithelial cells in the renal tubules of the kidney; [7] Müeller cells in the retina, [12] and skeletal muscles throughout the body. [13]

Agents transmitted by or blocking SMCT2

The SC-FAs transported into cells by SMCT2 include butyric, proprionic, pyruvic, lactic, acetic, and β-hydroxybutyric acids. SMCT2 also transports into cells the anionic forms of nicotinic acid [1] [7] [13] and gamma-hydroxybutyric acid. [2] Nonsteroidal anti-inflammatory drugs such as ibuprofen, ketoprofen, and fenoprofen bind to but are not transported by SMCT2. However, their binding blocks the binding and thereby transportation of the anionic SC-FAs and, presumably, the other anionic compounds that SMTC2 normally transports into cells. SMCT1 likewise transports these SC-FAs and nicotinic acid and is blocked by the cited anti-inflammatory drugs. [8] SMCT2 does have much lower affinities than SMCT1 for binding the SC-FAs and therefore is better suited to transport larger amounts of SC-FAs when their concentrations are high. [1] [13]

Functions of SMCT2

Gastrointestinal tract

SC-FAs inside the gastrointestinal tract come from the ingested food or are released by intestinal bacteria as fermentation products of the ingested food. SMCT2-bearing cells are located in the epithelial cells of the proximal portion (primarily the jejunum [14] ) of the small intestine but are not in the large intestine or cecum. Cells bearing the SMCT2 transporter, which has relatively low affinity for the SC-FAs, are suited to transport the high levels of dietary SC-FAs that are usually found in the proximal small intestine. Cells bearing the SMCT1 transporter, which has a relatively high affinity for the SC-FAs, are located in the large intestine and cecum. These cells are suited to take up the relatively low concentrations of the SC-FAs that are present in these sites. [1] [7] [14] The SC-FAs in the gastrointestinal tracts diffuse into the intestinal wall and transported by SMCT2 (and other intestinal SC-FA transporters [15] ) serve as energy sources for cells located in the intestinal wall and throughout the body. [8] They also stimulate various functions in cells of the intestine and throughout the body that express one of the SC-FA receptors, i.e., free fatty acid receptor 2, free fatty acid receptor 3, or hydroxycarboxylic acid receptor 2. (For the functions elicited by SC-FA's activation of these receptors see free fatty acid receptor 2 functions, free fatty acid receptor 3 functions, and hydroxycarboxylic acid receptor 2 functions.) [10] [11] [16] In addition, the SC-FAs that enter cells can directly activate certain signal transduction pathways and thereby elicit cellular responses independently of the three cited SC-FA receptors. [9]

Urinary tract

Studies in mice indicate that SMCT2 is located in the brush borders of the cells lining the kidney's proximal tubules with decreasing numbers of SMTC2-exressing cells in proximal tubule segments S1, S2, and S3. [8] In contrast, SMCT1 is mostly limited to the S3, i.e., most distal, segment of the proximal tubules. [5] [13] Thus, the kidney's proximal tubules consist of SMCT1-bearing cells that transfer the higher levels of SC-FAs found in the proximal tubules while the SMCT1-bearing cells are active in transferring the lower levels of SC-FAs in more distal part of the proximal tubules. [5] Other studies have shown that 1) mice lacking SMCT1 due to the knockout of their Slc8a5 gene had massive increases in the levels of lactic acid in their urine [17] and 2)C/ebpδ gene knockout mice (these mice do not express SCMT1 or SCMT2 in their kidney tissues) likewise have a marked increase in urinary excretion of lactic and also show decreases in their lactic acid blood levels. [18] These findings indicate that, in mice, SMCT1 is involved in the reabsorption of urine SC-FAs and that SMCT2 may also do so but studies on SLC5A12 gene knockout mice are needed to prove this. [17]

Eyes

Müller cells (also termed Müller glia) are critical non-neural components of the retina. They form and maintain the retina's structure, control retinal immune responses by, e.g., releasing inflammatory mediators and engulfing dead cell debris, and provide retinal neurons with essential nutrients, particularly the SC-FA, pyruvic acid. [19] SMCT2 has been detected in the Müller cells of mouse retinas and, based on indirect studies, the human rMC-1 Müeller cell line. These studies suggest that the function of SMCT2 in the retinal Müller cells of mice and humans is to take up SC-FAs and transfer of them to retinal neurons for their use as energy sources, particularly at times when other energy sources are less available. [12]

Skeletal muscle

Skeletal muscles accumulate lactic acid during their contractions. This lactic acid, particularly if in excess, moves out of the skeletal muscles and either diffuses into the systemic circulation or is transferred into skeletal muscles that do not have an excessive buildup of lactic acid. The transfer of lactic acid out and into human skeletal muscle has been thought to be mediated by the H+-coupled monocarboxylate transporters, MCT1 and MCT4. [20] However, a more recent study detected SMCT2 and SMCT1 in the skeletal muscles of mice and suggested that they may contribute to the transport of SC-FAs in skeletal muscles in mice. [13] Further studies are needed to determine if SCMT2 and/or SMCT1 are expressed by human skeletal muscle and contribute to the transport of lactic acid in mouse and/or human skeletal muscle.

See also

Sodium-coupled monocarboxylate transporter 1

Related Research Articles

<span class="mw-page-title-main">Butyric acid</span> Chemical compound

Butyric acid, also known under the systematic name butanoic acid, is a straight-chain alkyl carboxylic acid with the chemical formula CH3CH2CH2CO2H. It is an oily, colorless liquid with an unpleasant odor. Isobutyric acid is an isomer. Salts and esters of butyric acid are known as butyrates or butanoates. The acid does not occur widely in nature, but its esters are widespread. It is a common industrial chemical and an important component in the mammalian gut.

Glucose transporter type 4 (GLUT4), also known as solute carrier family 2, facilitated glucose transporter member 4, is a protein encoded, in humans, by the SLC2A4 gene. GLUT4 is the insulin-regulated glucose transporter found primarily in adipose tissues and striated muscle. The first evidence for this distinct glucose transport protein was provided by David James in 1988. The gene that encodes GLUT4 was cloned and mapped in 1989.

The solute carrier (SLC) group of membrane transport proteins include over 400 members organized into 66 families. Most members of the SLC group are located in the cell membrane. The SLC gene nomenclature system was originally proposed by the HUGO Gene Nomenclature Committee (HGNC) and is the basis for the official HGNC names of the genes that encode these transporters. A more general transmembrane transporter classification can be found in TCDB database.

Sodium-dependent glucose cotransporters are a family of glucose transporter found in the intestinal mucosa (enterocytes) of the small intestine (SGLT1) and the proximal tubule of the nephron. They contribute to renal glucose reabsorption. In the kidneys, 100% of the filtered glucose in the glomerulus has to be reabsorbed along the nephron. If the plasma glucose concentration is too high (hyperglycemia), glucose passes into the urine (glucosuria) because SGLT are saturated with the filtered glucose.

<span class="mw-page-title-main">Sodium/glucose cotransporter 1</span>

Sodium/glucose cotransporter 1 (SGLT1) also known as solute carrier family 5 member 1 is a protein in humans that is encoded by the SLC5A1 gene which encodes the production of the SGLT1 protein to line the absorptive cells in the small intestine and the epithelial cells of the kidney tubules of the nephron for the purpose of glucose uptake into cells. Recently, it has been seen to have functions that can be considered as promising therapeutic target to treat diabetes and obesity. Through the use of the sodium glucose cotransporter 1 protein, cells are able to obtain glucose which is further utilized to make and store energy for the cell.

<span class="mw-page-title-main">Sodium–hydrogen antiporter 3</span> Protein-coding gene in the species Homo sapiens

Sodium–hydrogen antiporter 3 also known as sodium–hydrogen exchanger 3 (NHE3) or solute carrier family 9 member 3 (SLC9A3) is a protein that in humans is encoded by the SLC9A3 gene.

<span class="mw-page-title-main">Free fatty acid receptor 3</span> Protein-coding gene in the species Homo sapiens

Free fatty acid receptor 3 protein is a G protein coupled receptor that in humans is encoded by the FFAR3 gene. GPRs reside on cell surfaces, bind specific signaling molecules, and thereby are activated to trigger certain functional responses in their parent cells. FFAR3 is a member of the free fatty acid receptor group of GPRs that includes FFAR1, FFAR2, and FFAR4. All of these FFARs are activated by fatty acids. FFAR3 and FFAR2 are activated by certain short-chain fatty acids (SC-FAs), i.e., fatty acids consisting of 2 to 6 carbon atoms whereas FFFAR1 and FFAR4 are activated by certain fatty acids that are 6 to more than 21 carbon atoms long. Hydroxycarboxylic acid receptor 2 is also activated by a SC-FA that activate FFAR3, i.e., butyric acid.

<span class="mw-page-title-main">Free fatty acid receptor 2</span> Protein-coding gene in the species Homo sapiens

Free fatty acid receptor 2 (FFAR2), also termed G-protein coupled receptor 43 (GPR43), is a rhodopsin-like G-protein coupled receptor. It is coded by the FFAR2 gene. In humans, the FFAR2 gene is located on the long arm of chromosome 19 at position 13.12. Like other GPCRs, FFAR2s reside on the surface membrane of cells and when bond to one of their activating ligands regulate the function of their parent cells. FFAR2 is a member of a small family of structurally and functionally related GPRs termed free fatty acid receptors (FFARs). This family includes three other receptors which, like FFAR2, are activated by certain fatty acids: FFAR1, FFAR3 (GPR41), and FFAR4 (GPR120). FFAR2 and FFAR3 are activated by short-chain fatty acids whereas FFAR1 and FFAR4 are activated by long-chain fatty acids.

<span class="mw-page-title-main">SUCNR1</span> Protein-coding gene in the species Homo sapiens

Succinate receptor 1 (SUCNR1), previously named G protein-coupled receptor 91 (GPR91), is a receptor that is activated by succinate, i.e., the anionic form of the dicarboxylic acid, succinic acid. Succinate and succinic acid readily convert into each other by gaining (succinate) or losing (succinic acid) protons, i.e., H+ (see Ions). Succinate is by far the predominant form of this interconversion in living organisms. Succinate is one of the intermediate metabolites in the citric acid cycle (also termed the TCA cycle or tricarboxylic acid cycle). This cycle is a metabolic pathway that operates in the mitochondria of virtually all eucaryotic cells. It consists of a series of biochemical reactions that serve the vital function of releasing the energy stored in nutrient carbohydrates, fats, and proteins. Recent studies have found that some of the metabolites in this cycle are able to regulate various physiological and pathological functions in a wide range of cell types. The succinyl CoA in this cycle may release its bound succinate; succinate is one of these mitochondrial-formed bioactive metabolites.

<span class="mw-page-title-main">Hydroxycarboxylic acid receptor 2</span> Protein-coding gene in the species Homo sapiens

Hydroxycarboxylic acid receptor 2 (HCA2), also known as GPR109A and niacin receptor 1 (NIACR1), is a protein which in humans is encoded (its formation is directed) by the HCAR2 gene and in rodents by the Hcar2 gene. The human HCAR2 gene is located on the long (i.e., "q") arm of chromosome 12 at position 24.31 (notated as 12q24.31). Like the two other hydroxycarboxylic acid receptors, HCA1 and HCA3, HCA2 is a G protein-coupled receptor (GPCR) located on the surface membrane of cells. HCA2 binds and thereby is activated by D-β-hydroxybutyric acid (hereafter termed β-hydroxybutyric acid), butyric acid, and niacin (also known as nicotinic acid). β-Hydroxybutyric and butyric acids are regarded as the endogenous agents that activate HCA2. Under normal conditions, niacin's blood levels are too low to do so: it is given as a drug in high doses in order to reach levels that activate HCA2.

<span class="mw-page-title-main">Monocarboxylate transporter 5</span> Protein-coding gene in the species Homo sapiens

Monocarboxylate transporter 5 is a protein that in humans is encoded by the SLC16A4 gene.

<span class="mw-page-title-main">Monocarboxylate transporter 4</span> Protein-coding gene in the species Homo sapiens

Monocarboxylate transporter 4 (MCT4) also known as solute carrier family 16 member 3 is a protein that in humans is encoded by the SLC16A3 gene.

<span class="mw-page-title-main">Sodium-coupled monocarboxylate transporter 1</span> Protein-coding gene in the species Homo sapiens

Sodium-coupled monocarboxylate transporter 1 (i.e., SMCT1) and sodium-coupled monocarboxylate transporter 2 (i.e., SMCT2) are plasma membrane transport proteins in the solute carrier family. They transport sodium cations in association with the anionic forms (see conjugated base) of certain short-chain fatty acids (i.e., SC-FAs) through the plasma membrane from the outside to the inside of cells. For example, propionic acid (i.e., CH
3CH
2CO
2H) in its anionic "propionate" form (i.e., CH
3CH
2CO−
2) along with sodium cations (i.e., Na+) are co-transported from the extracellular fluid into a SMCT1-epxressing cell's cytoplasm. Monocarboxylate transporters (MCTs) are also transport proteins in the solute carrier family. They co-transport the anionic forms of various compounds into cells in association with proton cations (i.e. H+). Four of the 14 MCTs, i.e. SLC16A1 (i.e., MCT1), SLC16A7 (i.e., MCT22), SLC16A8 (i.e., MCT3), and SLC16A3 (i.e., MCT4), transport some of the same SC-FAs anions that the SMCTs transport into cells. SC-FAs do diffuse into cells independently of transport proteins but at the levels normally occurring in tissues far greater amounts of the SC-FAs are brought into cells that express a SC-FA transporter.

<span class="mw-page-title-main">Monocarboxylate transporter 1</span>

Monocarboxylate transporter 1 is a ubiquitous protein that in humans is encoded by the SLC16A1 gene. It is a proton coupled monocarboxylate transporter.

<span class="mw-page-title-main">Iminoglycinuria</span> Medical condition

Iminoglycinuria is an autosomal recessive disorder of renal tubular transport affecting reabsorption of the amino acid glycine, and the imino acids proline and hydroxyproline. This results in excess urinary excretion of all three acids.

<span class="mw-page-title-main">Organic anion transporter 1</span> Protein-coding gene in the species Homo sapiens

The organic anion transporter 1 (OAT1) also known as solute carrier family 22 member 6 (SLC22A6) is a protein that in humans is encoded by the SLC22A6 gene. It is a member of the organic anion transporter (OAT) family of proteins. OAT1 is a transmembrane protein that is expressed in the brain, the placenta, the eyes, smooth muscles, and the basolateral membrane of proximal tubular cells of the kidneys. It plays a central role in renal organic anion transport. Along with OAT3, OAT1 mediates the uptake of a wide range of relatively small and hydrophilic organic anions from plasma into the cytoplasm of the proximal tubular cells of the kidneys. From there, these substrates are transported into the lumen of the nephrons of the kidneys for excretion. OAT1 homologs have been identified in rats, mice, rabbits, pigs, flounders, and nematodes.

<span class="mw-page-title-main">Monocarboxylate transporter 10</span> Protein-coding gene in the species Homo sapiens

Monocarboxylate transporter 10, also known as aromatic amino acid transporter 1 and T-type amino acid transporter 1 (TAT1) and solute carrier family 16 member 10 (SLC16A10), is a protein that in humans is encoded by the SLC16A10 gene. SLC16A10 is a member of the solute carrier family.

The lactate shuttle hypothesis describes the movement of lactate intracellularly and intercellularly. The hypothesis is based on the observation that lactate is formed and utilized continuously in diverse cells under both anaerobic and aerobic conditions. Further, lactate produced at sites with high rates of glycolysis and glycogenolysis can be shuttled to adjacent or remote sites including heart or skeletal muscles where the lactate can be used as a gluconeogenic precursor or substrate for oxidation. The hypothesis was proposed by professor George Brooks of the University of California at Berkeley.

Dicarboxylic aminoaciduria is a rare form of aminoaciduria which is an autosomal recessive disorder of urinary glutamate and aspartate due to genetic errors related to transport of these amino acids. Mutations resulting in a lack of expression of the SLC1A1 gene, a member of the solute carrier family, are found to cause development of dicarboxylic aminoaciduria in humans. SLC1A1 encodes for EAAT3 which is found in the neurons, intestine, kidney, lung, and heart. EAAT3 is part of a family of high affinity glutamate transporters which transport both glutamate and aspartate across the plasma membrane.

<span class="mw-page-title-main">Proton-coupled folate transporter</span> Mammalian protein found in Homo sapiens

The proton-coupled folate transporter is a protein that in humans is encoded by the SLC46A1 gene. The major physiological roles of PCFTs are in mediating the intestinal absorption of folate, and its delivery to the central nervous system.

References

  1. 1 2 3 4 5 Sivaprakasam S, Bhutia YD, Yang S, Ganapathy V (December 2017). "Short-Chain Fatty Acid Transporters: Role in Colonic Homeostasis". Comprehensive Physiology. 8 (1): 299–314. doi:10.1002/cphy.c170014. ISBN   9780470650714. PMC   6019286 . PMID   29357130.
  2. 1 2 3 Felmlee MA, Morse BL, Morris ME (January 2021). "γ-Hydroxybutyric Acid: Pharmacokinetics, Pharmacodynamics, and Toxicology". The AAPS Journal. 23 (1): 22. doi:10.1208/s12248-020-00543-z. PMC   8098080 . PMID   33417072.
  3. 1 2 Felmlee MA, Jones RS, Rodriguez-Cruz V, Follman KE, Morris ME (April 2020). "Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease". Pharmacological Reviews. 72 (2): 466–485. doi:10.1124/pr.119.018762. PMC   7062045 . PMID   32144120.
  4. ↑ Song W, Li D, Tao L, Luo Q, Chen L (January 2020). "Solute carrier transporters: the metabolic gatekeepers of immune cells". Acta Pharmaceutica Sinica. B. 10 (1): 61–78. doi:10.1016/j.apsb.2019.12.006. PMC   6977534 . PMID   31993307.
  5. 1 2 3 Gopal E, Umapathy NS, Martin PM, Ananth S, Gnana-Prakasam JP, Becker H, Wagner CA, Ganapathy V, Prasad PD (November 2007). "Cloning and functional characterization of human SMCT2 (SLC5A12) and expression pattern of the transporter in kidney". Biochimica et Biophysica Acta (BBA) - Biomembranes. 1768 (11): 2690–7. doi:10.1016/j.bbamem.2007.06.031. PMC   2703486 . PMID   17692818.
  6. ↑ "UniProt".
  7. 1 2 3 4 Iwanaga T, Kishimoto A (2015). "Cellular distributions of monocarboxylate transporters: a review". Biomedical Research (Tokyo, Japan). 36 (5): 279–301. doi: 10.2220/biomedres.36.279 . PMID   26522146.
  8. 1 2 3 4 Ganapathy V, Thangaraju M, Gopal E, Martin PM, Itagaki S, Miyauchi S, Prasad PD (2008). "Sodium-coupled monocarboxylate transporters in normal tissues and in cancer". The AAPS Journal. 10 (1): 193–9. doi:10.1208/s12248-008-9022-y. PMC   2751467 . PMID   18446519.
  9. 1 2 Elangovan S, Pathania R, Ramachandran S, Ananth S, Padia RN, Srinivas SR, Babu E, Hawthorn L, Schoenlein PV, Boettger T, Smith SB, Prasad PD, Ganapathy V, Thangaraju M (October 2013). "Molecular mechanism of SLC5A8 inactivation in breast cancer". Molecular and Cellular Biology. 33 (19): 3920–35. doi:10.1128/MCB.01702-12. PMC   3811868 . PMID   23918800.
  10. 1 2 Kimura I, Ichimura A, Ohue-Kitano R, Igarashi M (January 2020). "Free Fatty Acid Receptors in Health and Disease". Physiological Reviews. 100 (1): 171–210. doi: 10.1152/physrev.00041.2018 . PMID   31487233. S2CID   201845937.
  11. 1 2 Cosín-Roger J, Ortiz-Masia D, Barrachina MD, Calatayud S (October 2020). "Metabolite Sensing GPCRs: Promising Therapeutic Targets for Cancer Treatment?". Cells. 9 (11): 2345. doi: 10.3390/cells9112345 . PMC   7690732 . PMID   33113952.
  12. 1 2 3 Martin PM, Dun Y, Mysona B, Ananth S, Roon P, Smith SB, Ganapathy V (July 2007). "Expression of the sodium-coupled monocarboxylate transporters SMCT1 (SLC5A8) and SMCT2 (SLC5A12) in retina". Investigative Ophthalmology & Visual Science. 48 (7): 3356–63. doi:10.1167/iovs.06-0888. PMID   17591909.
  13. 1 2 3 4 5 6 Srinivas SR, Gopal E, Zhuang L, Itagaki S, Martin PM, Fei YJ, Ganapathy V, Prasad PD (December 2005). "Cloning and functional identification of slc5a12 as a sodium-coupled low-affinity transporter for monocarboxylates (SMCT2)". The Biochemical Journal. 392 (Pt 3): 655–64. doi:10.1042/BJ20050927. PMC   1316307 . PMID   16104846.
  14. 1 2 Bongarzone S, Barbon E, Ferocino A, Alsulaimani L, Dunn J, Kim J, Sunassee K, Gee A (2020). "Imaging niacin trafficking with positron emission tomography reveals in vivo monocarboxylate transporter distribution". Nuclear Medicine and Biology. 88–89: 24–33. doi:10.1016/j.nucmedbio.2020.07.002. PMC   7599079 . PMID   32683248.
  15. ↑ Teramae H, Yoshikawa T, Inoue R, Ushida K, Takebe K, Nio-Kobayashi J, Iwanaga T (August 2010). "The cellular expression of SMCT2 and its comparison with other transporters for monocarboxylates in the mouse digestive tract". Biomedical Research (Tokyo, Japan). 31 (4): 239–49. doi: 10.2220/biomedres.31.239 . PMID   20834181.
  16. ↑ Wuerch E, Urgoiti GR, Yong VW (July 2023). "The Promise of Niacin in Neurology". Neurotherapeutics. 20 (4): 1037–1054. doi:10.1007/s13311-023-01376-2. PMC  10457276. PMID   37084148.
  17. 1 2 Frank H, Gröger N, Diener M, Becker C, Braun T, Boettger T (September 2008). "Lactaturia and loss of sodium-dependent lactate uptake in the colon of SLC5A8-deficient mice". The Journal of Biological Chemistry. 283 (36): 24729–37. doi: 10.1074/jbc.M802681200 . PMC   3259809 . PMID   18562324.
  18. ↑ Thangaraju M, Ananth S, Martin PM, Roon P, Smith SB, Sterneck E, Prasad PD, Ganapathy V (September 2006). "c/ebpdelta Null mouse as a model for the double knock-out of slc5a8 and slc5a12 in kidney". The Journal of Biological Chemistry. 281 (37): 26769–73. doi: 10.1074/jbc.C600189200 . PMID   16873376.
  19. ↑ Gao H, A L, Huang X, Chen X, Xu H (May 2021). "Müller Glia-Mediated Retinal Regeneration". Molecular Neurobiology. 58 (5): 2342–2361. doi:10.1007/s12035-020-02274-w. PMID   33417229. S2CID   231192160.
  20. ↑ Juel C (November 2001). "Current aspects of lactate exchange: lactate/H+ transport in human skeletal muscle". European Journal of Applied Physiology. 86 (1): 12–6. doi:10.1007/s004210100517. PMID   11820315. S2CID   22025637.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.